Concepts (725)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Developing Countries | 87 | 2024 | 2803 | 6.560 |
Why?
|
| Delivery of Health Care | 78 | 2023 | 5255 | 5.560 |
Why?
|
| Investments | 15 | 2023 | 143 | 4.560 |
Why?
|
| Financing, Organized | 19 | 2023 | 204 | 4.330 |
Why?
|
| Tuberculosis | 47 | 2021 | 1957 | 4.320 |
Why?
|
| National Health Programs | 16 | 2019 | 439 | 3.960 |
Why?
|
| Research Support as Topic | 13 | 2020 | 697 | 3.880 |
Why?
|
| Health Policy | 40 | 2021 | 2650 | 3.630 |
Why?
|
| Public Sector | 11 | 2020 | 261 | 2.730 |
Why?
|
| Biomedical Research | 23 | 2023 | 3328 | 2.710 |
Why?
|
| International Cooperation | 27 | 2020 | 1417 | 2.660 |
Why?
|
| Financing, Government | 17 | 2021 | 467 | 2.650 |
Why?
|
| Health Services Accessibility | 46 | 2024 | 5241 | 2.560 |
Why?
|
| Financial Support | 12 | 2016 | 115 | 2.390 |
Why?
|
| HIV Infections | 60 | 2022 | 16936 | 2.380 |
Why?
|
| Malaria | 20 | 2017 | 1202 | 2.300 |
Why?
|
| Research | 13 | 2018 | 1954 | 2.290 |
Why?
|
| Health Services Needs and Demand | 21 | 2019 | 1390 | 2.280 |
Why?
|
| Health Care Reform | 16 | 2019 | 1250 | 2.250 |
Why?
|
| Health Expenditures | 22 | 2023 | 2309 | 2.190 |
Why?
|
| Government Programs | 17 | 2023 | 280 | 2.110 |
Why?
|
| Health Priorities | 9 | 2021 | 371 | 2.100 |
Why?
|
| Capital Financing | 6 | 2014 | 58 | 2.080 |
Why?
|
| Poverty | 26 | 2024 | 2613 | 2.070 |
Why?
|
| Communicable Disease Control | 18 | 2022 | 843 | 2.010 |
Why?
|
| Health Services | 14 | 2023 | 752 | 1.980 |
Why?
|
| Private Sector | 12 | 2021 | 392 | 1.950 |
Why?
|
| State Medicine | 8 | 2019 | 218 | 1.780 |
Why?
|
| Health Care Costs | 17 | 2021 | 3190 | 1.740 |
Why?
|
| Policy Making | 7 | 2021 | 536 | 1.730 |
Why?
|
| Income | 22 | 2022 | 1852 | 1.660 |
Why?
|
| Financial Management | 3 | 2023 | 161 | 1.540 |
Why?
|
| Communicable Diseases | 10 | 2022 | 869 | 1.530 |
Why?
|
| Primary Health Care | 16 | 2023 | 4592 | 1.510 |
Why?
|
| Public Health | 20 | 2022 | 2623 | 1.510 |
Why?
|
| Maternal Mortality | 9 | 2023 | 285 | 1.500 |
Why?
|
| Neoplasms | 29 | 2024 | 21715 | 1.470 |
Why?
|
| Goals | 13 | 2022 | 696 | 1.420 |
Why?
|
| Internationality | 6 | 2021 | 981 | 1.410 |
Why?
|
| Delivery of Health Care, Integrated | 8 | 2016 | 918 | 1.390 |
Why?
|
| Humans | 381 | 2024 | 746630 | 1.370 |
Why?
|
| World Health Organization | 18 | 2021 | 1298 | 1.310 |
Why?
|
| Cost of Illness | 13 | 2021 | 1876 | 1.270 |
Why?
|
| Resource Allocation | 5 | 2017 | 339 | 1.250 |
Why?
|
| Russia | 28 | 2019 | 381 | 1.230 |
Why?
|
| Leadership | 7 | 2021 | 1358 | 1.230 |
Why?
|
| Diabetes Mellitus | 18 | 2024 | 5774 | 1.180 |
Why?
|
| Disabled Persons | 5 | 2023 | 1191 | 1.180 |
Why?
|
| Capacity Building | 3 | 2018 | 254 | 1.120 |
Why?
|
| Cost-Benefit Analysis | 14 | 2021 | 5467 | 1.120 |
Why?
|
| Patient Acceptance of Health Care | 11 | 2020 | 3067 | 1.120 |
Why?
|
| Chronic Disease | 11 | 2021 | 9124 | 1.080 |
Why?
|
| Fund Raising | 3 | 2023 | 48 | 1.030 |
Why?
|
| Developed Countries | 7 | 2023 | 436 | 1.030 |
Why?
|
| Preventive Health Services | 3 | 2019 | 570 | 1.010 |
Why?
|
| Socioeconomic Factors | 29 | 2022 | 7685 | 1.000 |
Why?
|
| Caliciviridae Infections | 2 | 2016 | 29 | 0.990 |
Why?
|
| Financing, Personal | 2 | 2018 | 303 | 0.980 |
Why?
|
| Norovirus | 2 | 2016 | 36 | 0.980 |
Why?
|
| Politics | 10 | 2020 | 794 | 0.980 |
Why?
|
| Acquired Immunodeficiency Syndrome | 9 | 2013 | 2205 | 0.980 |
Why?
|
| Unemployment | 7 | 2016 | 210 | 0.970 |
Why?
|
| Computer Simulation | 10 | 2023 | 6148 | 0.930 |
Why?
|
| Tuberculosis, Pulmonary | 10 | 2012 | 807 | 0.910 |
Why?
|
| Self-Injurious Behavior | 2 | 2019 | 465 | 0.900 |
Why?
|
| Artificial Intelligence | 5 | 2021 | 2372 | 0.900 |
Why?
|
| Antitubercular Agents | 13 | 2012 | 1347 | 0.870 |
Why?
|
| Child Mortality | 4 | 2015 | 198 | 0.860 |
Why?
|
| Infectious Disease Transmission, Vertical | 5 | 2013 | 1328 | 0.850 |
Why?
|
| Hospital Administrators | 2 | 2018 | 55 | 0.840 |
Why?
|
| Hypertension | 12 | 2024 | 8366 | 0.830 |
Why?
|
| Health Personnel | 12 | 2022 | 3225 | 0.830 |
Why?
|
| Reminder Systems | 4 | 2013 | 376 | 0.820 |
Why?
|
| Africa South of the Sahara | 11 | 2017 | 717 | 0.810 |
Why?
|
| Privatization | 2 | 2020 | 41 | 0.810 |
Why?
|
| Health Education | 6 | 2022 | 1045 | 0.800 |
Why?
|
| Disease Outbreaks | 8 | 2020 | 1730 | 0.800 |
Why?
|
| Conservation of Natural Resources | 4 | 2017 | 202 | 0.780 |
Why?
|
| Models, Economic | 3 | 2020 | 717 | 0.770 |
Why?
|
| Transients and Migrants | 2 | 2021 | 153 | 0.760 |
Why?
|
| Mental Disorders | 7 | 2022 | 6639 | 0.750 |
Why?
|
| Harm Reduction | 4 | 2012 | 138 | 0.740 |
Why?
|
| Program Evaluation | 9 | 2019 | 2455 | 0.740 |
Why?
|
| Economic Recession | 3 | 2016 | 79 | 0.720 |
Why?
|
| Malaysia | 7 | 2023 | 107 | 0.720 |
Why?
|
| Diffusion of Innovation | 5 | 2015 | 710 | 0.690 |
Why?
|
| Insurance, Health | 10 | 2022 | 2473 | 0.680 |
Why?
|
| Health Planning | 5 | 2015 | 235 | 0.680 |
Why?
|
| Drug Resistance, Bacterial | 10 | 2023 | 1023 | 0.680 |
Why?
|
| India | 11 | 2022 | 2244 | 0.670 |
Why?
|
| Survival Analysis | 5 | 2020 | 10138 | 0.670 |
Why?
|
| Substance Abuse, Intravenous | 5 | 2012 | 527 | 0.670 |
Why?
|
| Prenatal Care | 3 | 2016 | 1083 | 0.660 |
Why?
|
| Maternal Welfare | 2 | 2011 | 113 | 0.660 |
Why?
|
| European Union | 7 | 2017 | 156 | 0.650 |
Why?
|
| Anti-HIV Agents | 10 | 2012 | 4413 | 0.650 |
Why?
|
| Child Health Services | 2 | 2017 | 655 | 0.650 |
Why?
|
| Time | 1 | 2020 | 540 | 0.650 |
Why?
|
| Healthcare Disparities | 15 | 2021 | 3226 | 0.640 |
Why?
|
| Cross-Sectional Studies | 47 | 2024 | 25184 | 0.640 |
Why?
|
| Anthelmintics | 1 | 2019 | 74 | 0.630 |
Why?
|
| Prevalence | 30 | 2024 | 15312 | 0.630 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 1612 | 0.630 |
Why?
|
| Helminthiasis | 1 | 2019 | 81 | 0.620 |
Why?
|
| Cities | 2 | 2017 | 523 | 0.620 |
Why?
|
| Anti-Infective Agents | 4 | 2023 | 972 | 0.600 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 7 | 2012 | 918 | 0.600 |
Why?
|
| Information Dissemination | 2 | 2016 | 1114 | 0.600 |
Why?
|
| Epidemics | 4 | 2021 | 508 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2022 | 3333 | 0.590 |
Why?
|
| Mathematics | 1 | 2019 | 716 | 0.590 |
Why?
|
| Directly Observed Therapy | 8 | 2012 | 138 | 0.590 |
Why?
|
| Female | 120 | 2024 | 382450 | 0.590 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 492 | 0.580 |
Why?
|
| Marburgvirus | 1 | 2016 | 19 | 0.580 |
Why?
|
| Quality of Health Care | 6 | 2021 | 4283 | 0.580 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2020 | 1999 | 0.570 |
Why?
|
| Program Development | 3 | 2012 | 1288 | 0.560 |
Why?
|
| Turkey | 5 | 2019 | 244 | 0.560 |
Why?
|
| Hepatitis | 2 | 2019 | 230 | 0.560 |
Why?
|
| Mortality | 9 | 2023 | 2854 | 0.540 |
Why?
|
| Prisons | 4 | 2012 | 160 | 0.540 |
Why?
|
| Charities | 2 | 2013 | 31 | 0.540 |
Why?
|
| Fees and Charges | 1 | 2017 | 191 | 0.530 |
Why?
|
| Hot Temperature | 1 | 2022 | 1415 | 0.530 |
Why?
|
| Work | 1 | 2017 | 195 | 0.530 |
Why?
|
| Hospitals | 7 | 2022 | 3855 | 0.520 |
Why?
|
| Social Values | 1 | 2016 | 226 | 0.520 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 1321 | 0.510 |
Why?
|
| Government | 4 | 2023 | 160 | 0.510 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 571 | 0.510 |
Why?
|
| Models, Theoretical | 8 | 2021 | 3552 | 0.510 |
Why?
|
| Primary Prevention | 5 | 2024 | 1168 | 0.510 |
Why?
|
| Decision Making, Organizational | 2 | 2013 | 138 | 0.500 |
Why?
|
| China | 10 | 2023 | 2294 | 0.500 |
Why?
|
| Academies and Institutes | 2 | 2014 | 312 | 0.500 |
Why?
|
| Computer-Assisted Instruction | 1 | 2018 | 360 | 0.500 |
Why?
|
| Population Surveillance | 4 | 2019 | 2587 | 0.500 |
Why?
|
| Antimalarials | 3 | 2012 | 903 | 0.500 |
Why?
|
| Cardiovascular Diseases | 14 | 2024 | 15319 | 0.500 |
Why?
|
| AIDS-Related Opportunistic Infections | 4 | 2010 | 663 | 0.500 |
Why?
|
| Hospitalization | 5 | 2022 | 10333 | 0.490 |
Why?
|
| Urban Health | 1 | 2017 | 535 | 0.490 |
Why?
|
| United Nations | 6 | 2018 | 156 | 0.490 |
Why?
|
| Adult | 77 | 2024 | 215192 | 0.490 |
Why?
|
| Anti-Retroviral Agents | 4 | 2022 | 1755 | 0.490 |
Why?
|
| Risk Reduction Behavior | 3 | 2011 | 1095 | 0.490 |
Why?
|
| Rural Population | 6 | 2022 | 2208 | 0.480 |
Why?
|
| Health Resources | 5 | 2019 | 906 | 0.480 |
Why?
|
| Urban Population | 5 | 2022 | 1990 | 0.480 |
Why?
|
| Diabetes Complications | 2 | 2021 | 1319 | 0.480 |
Why?
|
| Hospitals, Public | 2 | 2005 | 194 | 0.470 |
Why?
|
| Male | 92 | 2024 | 351420 | 0.470 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2016 | 2071 | 0.460 |
Why?
|
| Ebolavirus | 1 | 2016 | 252 | 0.460 |
Why?
|
| Child | 32 | 2022 | 78492 | 0.460 |
Why?
|
| Gastroenteritis | 1 | 2016 | 240 | 0.460 |
Why?
|
| Appointments and Schedules | 3 | 2013 | 428 | 0.460 |
Why?
|
| Drug Resistance, Microbial | 2 | 2014 | 852 | 0.460 |
Why?
|
| Colonialism | 1 | 2014 | 30 | 0.460 |
Why?
|
| Asia | 7 | 2013 | 603 | 0.460 |
Why?
|
| Health Surveys | 8 | 2022 | 3962 | 0.450 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2014 | 127 | 0.450 |
Why?
|
| Disease | 2 | 2016 | 660 | 0.450 |
Why?
|
| Perinatal Care | 2 | 2013 | 237 | 0.450 |
Why?
|
| Safety | 2 | 2017 | 1149 | 0.440 |
Why?
|
| Health Plan Implementation | 3 | 2013 | 331 | 0.440 |
Why?
|
| Healthy People Programs | 2 | 2012 | 53 | 0.440 |
Why?
|
| Health Services Research | 9 | 2020 | 1814 | 0.440 |
Why?
|
| Cost Savings | 3 | 2020 | 910 | 0.440 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2021 | 1896 | 0.440 |
Why?
|